Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic mesenchymal stem cells (Universitas Indonesia)
- Development stage
- Unknown
- Lead developer
- Prodia Stem Cell Indonesia
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Local Implantation
01
Overview
This investigational cell therapy, developed by Universitas Indonesia in collaboration with PT. Prodia Stem Cell Indonesia, consists of allogeneic mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord, or adipose tissue. The therapy is designed to treat non-union fractures and long bone defects by providing osteogenic cells that differentiate into bone-forming cells (osteoblasts). The MSCs are administered locally at the site of the bone defect in combination with a hydroxyapatite-calcium sulfate (HA-CaSO4) scaffold, which serves as a carrier and structural support. The treatment aims to promote bone regeneration and healing in cases where standard repair processes have failed. The therapy is being evaluated for both direct implantation and cryopreserved applications.
- Other names
- allogenic mesenchymal stem cellsallogenic MSCsallogenic bone marrow, umbilical cord, adipose mesenchymal stem cell
Beyond the preview
Go deeper on allogeneic mesenchymal stem cells (Universitas Indonesia).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic mesenchymal stem cells (Universitas Indonesia).